Stockscreener 앱 받기
1.63
1.88%
0.03
전일 마감가:
$1.60
열려 있는:
$1.62
하루 거래량:
36,121
Relative Volume:
0.71
시가총액:
$11.45M
수익:
순이익/손실:
주가수익비율:
-
EPS:
-
순현금흐름:
1주 성능:
-2.40%
1개월 성능:
-13.76%
6개월 성능:
-47.42%
1년 성능:
+0.00%
1일 변동 폭
$0.00
$0.00
1주일 범위
$1.60
$1.7398
52주 변동 폭
$1.2316
$15.50
Regentis Biomaterials Ltd. Stock (RGNT) Company Profile
Compare RGNT vs ISRG, BDX, RMD, MDLN, ALC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RGNT
Regentis Biomaterials Ltd.
|
1.63 | 11.45M | 0 | 0 | 0 | 0.00 |
ISRG
Intuitive Surgical Inc
|
427.64 | 151.08B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
188.89 | 51.45B | 21.37B | 1.41B | 3.07B | 3.9437 |
RMD
Resmed Inc
|
234.60 | 32.99B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
35.76 | 31.37B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
64.35 | 31.11B | 10.63B | 819.00M | 1.59B | 1.6577 |
Regentis Biomaterials Ltd. 주식(RGNT)의 최신 뉴스
Regentis Biomaterials to Present at the 2026 ThinkEquity Conference on October 15 in New York City - The Globe and Mail
A knee cartilage implant study is more than 50% enrolled - Stock Titan
Regentis Biomaterials Is Addressing the ‘Short-Term Relief, Long-Term Failure’ Problem in Knee Cartilage - Benzinga
Regentis Biomaterials and the Shift from Symptom Management to Structural Repair in Knee Cartilage Care - benzinga.com
Regentis Biomaterials and the Shift from Symptom Management to Structural Repair in Knee Cartilage Care - Barchart.com
REGENTIS BIOMATERIALS LTD. SEC Filing (Sep 23, 2026) - Stock Titan
Stray alert from IBN tagged to Regentis Biomaterials withdrawn - marketscreener.com
IBN Announces Latest Episode of The BioMedWire Podcast - GlobeNewswire
IBN Announces Latest Episode of The BioMedWire Podcast Featuring Dr. Ehud Geller, CEO of Regentis Biomaterials Ltd. - Yahoo Finance
Regentis Biomaterials (RGNT) Advances GelrinC as a Potential New Approach to Knee Cartilage Repair - Yahoo Finance
Regentis Biomaterials (NYSE American: RGNT) Advances GelrinC as a Potential New Approach to Knee Cartilag - Benzinga
Regentis Biomaterials Ltd. Research & Ratings | RGNT - Barron's
Regentis Biomaterials Ltd. Stock Grades | RGNT - Barron's
Regentis Biomaterials Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 - marketscreener.com
Regentis Biomaterials Reports First Half 2026 Financial Results and Provides Corporate Update - finance.yahoo.com
Regentis (NYSE American: RGNT) says cash lasts to 2027 but issues going‑concern warning - Stock Titan
Regenerative Hydrogel Is Redefining Cartilage Repair as Regentis Advances GelrinC - Yahoo Finance
Regentis Biomaterials (RGNT) Moves GelrinC Along Parallel US Clinical and European Commercial Tracks - Yahoo Finance
Regentis Biomaterials (RGNT) Builds a Manufacturing and Intellectual Property Powerhouse for the Global Cartilage Repair Market - Yahoo Finance
Regentis Biomaterials Ltd. Revenue Breakdown – AMEX:RGNT - TradingView
Regentis Biomaterials (RGNT) Targets $3B Cartilage Repair Market with Cell-Free Gelrin C - Yahoo Finance
Regentis Biomaterials (RGNT) Targets $3B Cartilage Repair Market with Cell-Free Gelrin C - newmediawire.com
Regentis Biomaterials (RGNT) Receives European Approval for Next-Generation GelrinC Manufacturing Process - Yahoo Finance
Regentis Biomaterials Ltd Actuals & Estimates (AMEX:RGNT) - TradingView
Why Is Regentis Biomaterials Stock Rising On Wednesday? - Benzinga
Regentis Biomaterials Slips 9% After Soaring 506% On Monday — Here's Why RGNT Stock Is Trending - Benzinga
RGNT Stock Erupts As GelrinC European Rollout Plans Ignite Trading - StocksToTrade
Why Did RGNT Stock Surge More Than 850% Today? - Yahoo Finance
RGNT Stock Slides After Volatile Spike Draws Trader Focus - timothysykes.com
RGNT Stock Rockets On High-Volume Breakout Volatility - StocksToTrade
Regentis Biomaterials (RGNT) Advances European Commercial Launch Plans for GelrinC - Yahoo Finance
10-minute knee implant shows about 2x pain relief vs microfracture - stocktitan.net
Regentis Biomaterials (RGNT) Advances Simplified Cartilage Repair Platform Toward Key Commercial Milestones - Yahoo Finance
Regentis Biomaterials (RGNT) Targets Major Gap in Knee Cartilage Repair Market with Off-the-Shelf Regenerative Implant - Yahoo Finance
RGNT - Finviz
Regentis Biomaterials (RGNT) Is 'One to Watch' - Yahoo Finance
Regentis Biomaterials Ltd. Announces Closing of Initial Public Offering - Yahoo Finance
Regentis Biomaterials Ltd. (RGNT) 재무 분석
Regentis Biomaterials Ltd. (RGNT)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
21.89%
12.50%
자본화:
|
볼륨(24시간):